BVF PARTNERS L P/IL Insider Trading $FPRX FIVE PRIME THERAPEUTICS, INC.
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in FIVE PRIME THERAPEUTICS, INC.
Trading Symbol: FPRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL:
Holdings: 670,695 shares
Current Value: $30,436,139
Latest Transaction: Nov 13 2020
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in FIVE PRIME THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 13 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | Sell | S | 20.19 | 502,649 | 10,146,825 | 81,263 | 583.9 K to 81.3 K (-86.08 %) | |
Nov 13 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | Sell | S | 20.19 | 2,949,477 | 59,540,207 | 485,513 | 3.4 M to 485.5 K (-85.87 %) | |
Nov 13 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | Sell | S | 20.19 | 3,941,214 | 79,560,105 | 670,695 | 4.6 M to 670.7 K (-85.46 %) | |
Oct 08 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.04 | 25,107 | 126,414 | 566,223 | 541.1 K to 566.2 K (+4.64 %) |
Oct 08 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.04 | 162,352 | 817,442 | 3,281,151 | 3.1 M to 3.3 M (+5.21 %) |
Oct 08 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.04 | 157,782 | 794,432 | 4,336,875 | 4.2 M to 4.3 M (+3.78 %) |
Sep 24 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.80 | 32 | 122 | 541,116 | 541.1 K to 541.1 K (+0.01 %) |
May 18 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.10 | 4,476 | 18,352 | 541,084 | 536.6 K to 541.1 K (+0.83 %) |
May 18 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.10 | 39,810 | 163,221 | 3,118,799 | 3.1 M to 3.1 M (+1.29 %) |
May 18 2020 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.10 | 249,301 | 1,022,134 | 4,179,093 | 3.9 M to 4.2 M (+6.34 %) |
Dec 26 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.05 | 32,606 | 132,054 | 536,608 | 504 K to 536.6 K (+6.47 %) |
Dec 26 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.05 | 201,096 | 814,439 | 3,078,989 | 2.9 M to 3.1 M (+6.99 %) |
Dec 26 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.05 | 281,318 | 1,139,338 | 3,929,792 | 3.6 M to 3.9 M (+7.71 %) |
Dec 11 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.02 | 2,397 | 9,630 | 504,002 | 501.6 K to 504 K (+0.48 %) |
Dec 11 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.02 | 18,729 | 75,244 | 2,877,893 | 2.9 M to 2.9 M (+0.66 %) |
Dec 11 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.02 | 113,874 | 457,489 | 3,648,474 | 3.5 M to 3.6 M (+3.22 %) |
Nov 26 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.40 | 81,857 | 278,322 | 501,605 | 419.7 K to 501.6 K (+19.50 %) |
Nov 26 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.40 | 462,056 | 1,571,037 | 2,859,164 | 2.4 M to 2.9 M (+19.28 %) |
Nov 26 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.40 | 576,097 | 1,958,787 | 3,534,600 | 3 M to 3.5 M (+19.47 %) |
Nov 07 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 70,921 | 283,684 | 419,748 | 348.8 K to 419.7 K (+20.33 %) |
Nov 07 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 400,470 | 1,601,880 | 2,397,108 | 2 M to 2.4 M (+20.06 %) |
Nov 07 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 496,721 | 1,986,884 | 2,958,503 | 2.5 M to 3 M (+20.18 %) |
Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 504 | 1,940 | 348,827 | 348.3 K to 348.8 K (+0.14 %) |
Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 2,913 | 11,214 | 1,996,638 | 2 M to 2 M (+0.15 %) |
Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 3,416 | 13,150 | 2,461,782 | 2.5 M to 2.5 M (+0.14 %) |
Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.89 | 1,456 | 5,667 | 348,323 | 346.9 K to 348.3 K (+0.42 %) |
Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.89 | 8,236 | 32,055 | 1,993,725 | 2 M to 2 M (+0.41 %) |
Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.89 | 10,389 | 40,435 | 2,458,366 | 2.4 M to 2.5 M (+0.42 %) |
Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.90 | 240 | 935 | 346,867 | 346.6 K to 346.9 K (+0.07 %) |
Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.90 | 1,133 | 4,415 | 1,985,489 | 2 M to 2 M (+0.06 %) |
Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.90 | 1,027 | 4,002 | 2,447,977 | 2.4 M to 2.4 M (+0.04 %) |
Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 2,155 | 8,075 | 346,627 | 344.5 K to 346.6 K (+0.63 %) |
Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 12,899 | 48,336 | 1,984,356 | 2 M to 2 M (+0.65 %) |
Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 15,728 | 58,938 | 2,446,950 | 2.4 M to 2.4 M (+0.65 %) |
Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 1,629 | 6,100 | 344,472 | 342.8 K to 344.5 K (+0.48 %) |
Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 57,723 | 216,155 | 1,971,457 | 1.9 M to 2 M (+3.02 %) |
Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 76,036 | 284,732 | 2,431,222 | 2.4 M to 2.4 M (+3.23 %) |
Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 3,200 | 11,986 | 2,355,186 | 2.4 M to 2.4 M (+0.14 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.68 | 4,689 | 17,270 | 342,843 | 338.2 K to 342.8 K (+1.39 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.68 | 24,716 | 91,029 | 1,913,734 | 1.9 M to 1.9 M (+1.31 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.68 | 31,007 | 114,199 | 2,351,986 | 2.3 M to 2.4 M (+1.34 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 24,425 | 91,594 | 338,154 | 313.7 K to 338.2 K (+7.79 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 14,242 | 53,382 | 313,729 | 299.5 K to 313.7 K (+4.76 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 138,609 | 519,784 | 1,889,018 | 1.8 M to 1.9 M (+7.92 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 80,821 | 302,933 | 1,750,409 | 1.7 M to 1.8 M (+4.84 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 168,640 | 632,400 | 2,320,979 | 2.2 M to 2.3 M (+7.84 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 98,333 | 368,572 | 2,152,339 | 2.1 M to 2.2 M (+4.79 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 991 | 3,704 | 299,487 | 298.5 K to 299.5 K (+0.33 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 7,314 | 27,336 | 1,669,588 | 1.7 M to 1.7 M (+0.44 %) |
Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 7,695 | 28,760 | 2,054,006 | 2 M to 2.1 M (+0.38 %) |
Page: 1